If you have a prescribed need for med, so be it
All compounds referenced on this page are intended exclusively for laboratory and preclinical research purposes
The combination of semaglutide with other treatments should be carefully managed by a healthcare provider to optimize therapeutic outcomes and minimize the risk of hypoglycemia, especially when used with insulin or sulfonylureas
While initial studies have not raised significant concerns regarding cardiovascular events with semaglutide use in UC, continued surveillance and post marketing studies are warranted to further elucidate its cardiovascular safety profile in this patient population
[2] Chang CH, Tsai WC, Hsu YH, Pang JH
(Nasdaq: CLDX), a public biopharmaceutical company